Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.

Events

Event When
Full-Year 2019 Financial Results reporting* February 6, 2020
First Quarter 2020 Financial Results reporting* April 23, 2020
Annual General Meeting of Shareholders May 13, 2020
Half-Year 2020 Financial Results reporting* July 23, 2020

*We will be in a silent period for 10 days ahead of the financial reporting.

Stay informed

Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.

Stay informed

Social Media

Idorsia is active on social media – follow our channels to get a more personal view on the company.

Social Media

Media center

Idorsia provides images, fact sheets and B-roll to download or support you with your article.

Media center

Contact

Contact

Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications

Media Relations

Resources in German

Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.